1.1 本指南提供了一套一致的太空飞行参与者（SFP）验收指南，将为商业载人航天运营商制定自己的亚轨道飞行医疗计划提供建议。 1.2 单位-- 以国际单位制表示的数值应视为标准。本标准中不包括其他计量单位。 1.3 FAA监管机构:2004年，国会授予FAA监督新兴商业载人航天行业安全的权力，但限制了其规则制定权。为了确保该行业有充足的学习期来发展和创新，国会禁止美国联邦航空管理局发布任何关于运载火箭设计或操作的法规，以保护机组人员和太空飞行参与者的健康和安全，除非发生死亡、重伤或紧急情况。 最初的禁令于2012年到期，但国会将其延长至2015年，然后再次延长至2016年，最后延长至2023年10月1日。SFP的医疗要求不在2004年《修正法案》中，目前的暂停期将于2023年到期。 美国交通部部长有权根据 《美国法典》第51篇§50905（b）（6） : （A） 部长可发布条例，要求太空飞行参与者在根据本章发射或重返大气层之前接受适当的身体检查。本分段应在2004年《商业航天发射修正法案》颁布之日起三年后停止生效。 （B） 部长可发布附加条例，为太空飞行参与者制定合理要求，包括医疗和培训要求。 此类规定在2004年《商业航天发射修正法案》颁布之日起3年内无效。 然而，到目前为止，USDOT拒绝行使这一权力。 1.4 本标准并非旨在解决与其使用相关的所有安全问题（如有）。本标准的使用者有责任在使用前制定适当的安全、健康和环境实践，并确定监管限制的适用性。 1.5 本国际标准是根据世界贸易组织技术性贸易壁垒委员会发布的《关于制定国际标准、指南和建议的原则的决定》中确立的国际公认的标准化原则制定的。 ===意义和用途====== 3.1 与 1.1 ，商业载人航天公司应遵循本文件建议的指南。这些指南可以根据每家公司的具体航天系统、操作程序、安全标准和风险状况进行定制。 3.2 根据《美国法典》第51篇第50905（b）条的规定，目前需要公司 （5） 告知太空飞行参与者与任务相关的风险，但某些医疗状况的具体风险尚未确定。本指南中的SFP医疗标准和指南应被视为最低建议，政府机构和运营商可以选择额外的医疗和运营限制。

1.1 This guide provides a consensus set of Space Flight Participant (SFP) acceptance guidelines that will serve as advice to commercial human spaceflight operators as they develop their own medical programs for suborbital flights. 1.2 Units— The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard. 1.3 FAA regulatory authority: In 2004 Congress granted the FAA the authority to oversee the safety of the emerging commercial human space flight industry, but limited its rulemaking authority. To ensure the industry had an ample learning period to develop and innovate, Congress prohibited the FAA from issuing any regulations governing the design or operation of a launch vehicle intended to protect the health and safety of crew and space flight participants unless there was a death, serious injury, or close call. The original prohibition expired in 2012, but Congress extended it to 2015, then extended it again to 2016, and finally to October 1, 2023. SFP medical requirements are not under the Amendments Act of 2004 current moratorium that will expire in 2023. The Secretary of the US Department of Transportation (USDOT) has authority to issue regulations regarding SFP medical requirements under Title 51 USC § 50905 (b) (6) : (A) The Secretary may issue regulations requiring space flight participants to undergo an appropriate physical examination prior to a launch or reentry under this chapter. This subparagraph shall cease to be in effect three years after the date of enactment of the Commercial Space Launch Amendments Act of 2004. (B) The Secretary may issue additional regulations setting reasonable requirements for space flight participants, including medical and training requirements. Such regulations shall not be effective before the expiration of 3 years after the date of enactment of the Commercial Space Launch Amendments Act of 2004. However, USDOT has declined to exert this authority thus far. 1.4 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use. 1.5 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee. ====== Significance And Use ====== 3.1 In keeping with 1.1 , commercial human spaceflight companies should follow the guidelines recommended by this document. These guidelines may be tailored to fit each company's specific spaceflight systems, operational procedures, safety standards, and risk profiles. 3.2 Companies currently are required under Title 51 USC § 50905(b) (5) to inform spaceflight participants about the mission-related risk, but the specific risk of certain medical conditions has yet to be determined. The SFP medical standards and guidelines in this guide shall be considered the minimum recommended, and governmental agencies and operators have the option for additional medical and operational constraints.